Advertisement
Home 2017

Yearly Archives: 2017

Continuous positive airway pressure may be a more effective treatment than laparoscopic gastric banding for control of severe obstructive sleep apnea

CPAP May Be Superior to Gastric Banding for Severe Sleep Apnea

0
At 9 months, apnea-hypopnea index is significantly lower with CPAP than with laparoscopic banding
Among patients with childhood-onset type 1 diabetes

Risk of End-Stage Renal Disease Low With Type 1 Diabetes

0
Findings among a large study of Norwegian children followed for 40-plus years
Physicians have two extra weeks to preview their 2016 performance information as a result of a mistake related to the Centers for Medicare &#amp; Medicaid Services' Physician Compare online resource

Doctors Have Extra Two Weeks to Preview Performance Data

0
Due to technical issue with Physician Compare, CMS extending time frame for physicians to view data
Many patients with a previous West Nile virus infection have abnormalities on neurologic examination several years after they were infected

Neurologic Abnormalities Identified After West Nile Virus

0
Half of patients with history of West Nile virus have abnormality on neurologic exam years after infection
For women with ovarian cancer who underwent both surgery and adjuvant chemotherapy

Average Cost of Care in Year After Ovarian Cancer Surgery ~$100K

0
Patients bear about 3 percent of these costs in the form of out-of-pocket expenses
Hearing loss among U.S. adolescents seems not to be increasing

Hearing Loss Among U.S. Adolescents Is Not Increasing

0
All subgroups of degree, frequency, and laterality had lower prevalence of hearing loss in 2010 vs. 2006

The American Society of Nephrology, Oct. 31-Nov.5

0
The Annual Meeting of the American Society of Nephrology, Kidney Week 2017 The annual meeting of the American Society of Nephrology was...
Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration as the first drug to treat certain adults patients with Erdheim-Chester disease.

Zelboraf Approved for Use in Erdheim-Chester Disease

0
Kinase inhibitor (vemurafenib) for use in patients with BRAF V600 mutation
Alcohol use is associated with certain types of cancer

ASCO Issues Statement Regarding Alcohol and Cancer

0
Alcohol-related cancers account for 5.5 percent of all cancers treated annually worldwide
For patients with acute severe bleeding

Delay in Tranexamic Acid Administration Reduces Benefit

0
Survival benefit decreases by 10 percent for every 15-minute delay in treatment for severe bleeding